"The Drug Controller General of India (DCGI) has issued for restricted use, Emergency Use Authorisation (EUA) for the generic version of Tocilizumab," it said in a statement. India has faced a huge shortage of tocilizumab, used to treat critically ill Covid patients-during the Covid surge.
